Essential Biomarker Testing in GI Cancers
Listen to John L. Marshall, MD, discuss contemporary biomarker testing considerations in gastrointestinal tumors, including colon, gastric, biliary, and pancreas cancers.
Decera Clinical Education Oncology Podcast · John L. Marshall MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, John L. Marshall, MD, discusses current molecular testing considerations in the treatment of patients with gastrointestinal tumors, including:
- Current testing approaches, including IHC and PD-L1 assays and next-generation sequencing
- Tumor agnostic testing: MSI, TMB, and NTRK fusion testing
- Colon cancer: RAS, BRAF, and HER2
- Gastric cancer: PD-L1, HER2, and more
- Pancreatic cancer: BRCA
- Biliary cancers: FGFR and IDH1
- Liquid biopsies
- When to test
Presenter:
John L. Marshall, MD
Chief, Division of Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC
Content based on an online CME program supported by educational grants from Bayer and Merck, Sharp & Dohme.
Link to full program:
https://bit.ly/3j4hV8J
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.